PND13 Budget Impact Analysis and Update of a Cost Effectiveness Evaluation for Alpha (α) Polymorph Rifaximin for the Treatment of Acute Hepatic Encephalopathy
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1937
https://www.valueinhealthjournal.com/article/S1098-3015(12)03650-9/fulltext
Title :
PND13 Budget Impact Analysis and Update of a Cost Effectiveness Evaluation for Alpha (α) Polymorph Rifaximin for the Treatment of Acute Hepatic Encephalopathy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03650-9&doi=10.1016/j.jval.2012.08.1937
First page :
A547
Section Title :
Neurological Disorders
Open access? :
No
Section Order :
1419